These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

457 related items for PubMed ID: 22460183

  • 1. IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine.
    Pozzi C, Andrulli S, Pani A, Scaini P, Roccatello D, Fogazzi G, Pecchini P, Rustichelli R, Finocchiaro P, Del Vecchio L, Locatelli F.
    J Nephrol; 2013; 26(1):86-93. PubMed ID: 22460183
    [Abstract] [Full Text] [Related]

  • 2. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C, Torres DD, Rossini M, Pesce F, Schena FP.
    Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Up-regulation of urinary markers predict outcome in IgA nephropathy but their predictive value is influenced by treatment with steroids and azathioprine.
    Stangou M, Papagianni A, Bantis C, Moisiadis D, Kasimatis S, Spartalis M, Pantzaki A, Efstratiadis G, Memmos D.
    Clin Nephrol; 2013 Sep; 80(3):203-10. PubMed ID: 23611517
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy.
    Pozzi C, Andrulli S, Pani A, Scaini P, Del Vecchio L, Fogazzi G, Vogt B, De Cristofaro V, Allegri L, Cirami L, Procaccini AD, Locatelli F.
    J Am Soc Nephrol; 2010 Oct; 21(10):1783-90. PubMed ID: 20634300
    [Abstract] [Full Text] [Related]

  • 13. Can immunosuppressive drugs slow the progression of IgA nephropathy?
    Goumenos D, Ahuja M, Shortland JR, Brown CB.
    Nephrol Dial Transplant; 1995 Oct; 10(7):1173-81. PubMed ID: 7478120
    [Abstract] [Full Text] [Related]

  • 14. The retrospective analysis of 343 Czech patients with IgA nephropathy--one centre experience.
    Maixnerova D, Bauerova L, Skibova J, Rysava R, Reiterova J, Merta M, Honsova E, Tesar V.
    Nephrol Dial Transplant; 2012 Apr; 27(4):1492-8. PubMed ID: 21891776
    [Abstract] [Full Text] [Related]

  • 15. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T, Najafi I, Salimi BH, Broomand B.
    Ren Fail; 2011 Apr; 33(6):572-7. PubMed ID: 21663387
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy.
    Yagi K, Okada M, Yanagida H, Kuwajima H, Ikeda M, Sugimoto K, Takemura T.
    Clin Exp Nephrol; 2003 Dec; 7(4):270-4. PubMed ID: 14712355
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tonsillectomy with steroid pulse therapy has more effect on the relapse rate than steroid pulse monotherapy in IgA nephropathy patients.
    Ohya M, Otani H, Minami Y, Yamanaka S, Mima T, Negi S, Yukawa S, Shigematsu T.
    Clin Nephrol; 2013 Jul; 80(1):47-52. PubMed ID: 23557791
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.